Malu Mader recalls the diagnosis of liver cancer at 25 years

Malu Mader recalls the diagnosis of liver cancer at 25 years


At 58, Malu Mader recalls the traumatic experience of a benign tumor in the liver and receives medical advice on risks

HTML[data-range=”xlarge”] IMG.IMG-E6C44D250E33EB252F3F9374018A18A18F5257CJL2B {Width: 774PX Height: 435px; } html[data-range=”large”] IMG.IMG-E6C44D250E33EB252F3F9374018A18A18F5257CJL2B {Width: 548px figure; Height: 308px; } html[data-range=”small”] IMG.IMG-E6C44D250E3EB252F3F9374018A18A18F5257CJL2B, HTML[data-range=”medium”] IMG.IMG-E6C44D250E33EB252F3F9374018A18A18F5257CJL2B {Width: 564px image; Height: 317px; } html[data-range=”small”] . Article___MAGE-MOB, HTML[data-range=”medium”] . Margin: 0 Auto 30px; }




In participation in the program Encounter And in an interview with Caras Brasil, Malu Mader recalled When, at the age of 25, he was diagnosed with a benign liver cancer in 2017. The episode was marked by the hospital in New York, where he was curated by specialized doctors and left a lasting emotional impact. Despite fear, the tumor has been correctly identified as non -carcinogen.

Diagnosis and treatment in the United States

Malu recalled that he had traveled to New York looking for care with “a beast doctor”, remembering that the experience of the hospital was “very traumatic”. The choice of a specialized medical center ensured safety and effectiveness from the first diagnosis.

What does the expert say

The oncologist Dr. Jorge Abyssamra, of the Araldo Vieira de Carvalho Institute, explained the main differences between liver cancers in young people:

Benign tumors, such as liver adenoma, are more frequent among healthy young people and young people, in particular women in prolonged contraceptives.

Maligny tumors (e.g. hepocellular carcinoma EG EG) are rare in this age group, usually associated with previous conditions such as hepatitis or cirrhosis.

Although Benigni, these tumors can trigger a significant emotional impact, requesting adequate clinical follow -up.

Individualized treatment and follow -Up

As pointed out by Dr. AbissamraThe treatment varies according to specific characteristics, such as the size of the tumor and the site:

  • Small and asymptomatic tumors can be monitored only.
  • Surgical interventions are indicated in risk (growth, symptoms, complications).
  • The choice is personalized, respecting the context and patient’s clinical desires

Global scenario and progress in oncology

According to WHO statistics, the number of new cases of cancer has reached 20 million per year by 2022, exceeding the projections for 2030 – an overview that strengthens the importance of progress in diagnosis and treatment. Dr. Abissamra stresses that even in the face of this scenario, the scenario is significantly advanced in protocols and medical technology.

Source: Terra

You may also like